Dose Ranging Study of Combined Haemophilus Influenzae Type B-Meningococcal Serogroups CY (Hib-MenCY-TT) Vaccine

Clinical trial NCT00127855 · COMPLETED

Trial details

NCT number: NCT00127855
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Haemophilus Influenzae Type b Neisseria Meningitidis

Start date: 2003-03-01
Primary completion: 2004-02-01
Enrollment: 409

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.